Should rosuvastatin be withdrawn from the market?
- 1 October 2004
- journal article
- Published by Elsevier in The Lancet
- Vol. 364 (9445) , 1579-80
- https://doi.org/10.1016/s0140-6736(04)17304-2
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Safety and efficacy of rosuvastatinThe Lancet, 2004
- The statin warsThe Lancet, 2003
- Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemiaThe American Journal of Cardiology, 2001